Table 1—

Information given to patients on drug use and utility

Sympathomimetic drugs of short half-life, – β2-agonists – (e.g. salbutamol, terbutaline)
 Fast-acting bronchodilator drugs useful for the control of acute asthma symptoms
 Not useful for long-term asthma control
 An increase in the daily requirement for β2-agonists means decompensation of the disease and, consequently, an increase in the need for anti-inflammatory agents to control the asthma
Sympathomimetic drugs of long half-life (e.g. formoterol, salmeterol)
 Long-acting bronchodilator drugs
 Should not be used for the control of acute asthma symptoms, which should be treated with salbutamol or terbutaline
 Doses cannot be increased without the physician's permission
Theophylline
 Bronchodilator drug
 Doses cannot be increased without the physician's permission
Inhaled steroids (e.g. beclomethasone, budesonide, fluticasone)
 Anti-inflammatory agent
 Should always be used after bronchodilators
 Very useful for achieving long-term stabilisation of the disease process; currently considered the most important medication for treating asthma
 Does not relieve acute symptoms of asthma because rescue effect is lacking
 It is necessary to take this medication regularly in order to have a normal life over the years
Oral steroids (e.g. prednisone, methylprednisone, deflazacort)
 Anti-inflammatory agents which are sometimes necessary to stabilise exacerbations of acute asthma
 Should be used appropriately following a physician's instructions
 No need to be afraid of this modality of treatment if its use is adequate
 Short-term courses are generally free from adverse events
Antibiotics
 Acute episodes of asthma exacerbation are often confused with respiratory tract infections
 Acute episodes of asthma exacerbation should be treated with anti-inflammatory agents and not with antibiotics
 Antibiotics should be taken only in the case of bacterial decompensation with mucopurulent sputum (green)